Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nextpower Inc. Common Stock (NXT) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Nextpower Inc. Common StockTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Nextpower Inc. Common Stock vs Zimmer Biomet Holdings Inc — how do they compare? Nextpower Inc. Common Stock trades at $81.37 (market cap $13.47B), while Zimmer Biomet Holdings Inc trades at $92.24 (market cap $17.56B). The key difference: Zimmer Biomet Holdings Inc is the larger of the two by market cap, and Zimmer Biomet Holdings Inc pays a 1.04% dividend while Nextpower Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nextpower Inc. Common Stock for 0 Days and Zimmer Biomet Holdings Inc for 89 Days on average.

NXTZBH
Market Cap
$13.47B$17.56B
Volume
2,009,3022,298,426
Sector
EnergyHealth
52-Week High
$156.40$103.98
52-Week Low
$77.93$79.58
Typical Hold Time
0 Days89 Days
Enterprise Value
$12.92B$24.63B
Dividend Yield
—1.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nextpower Inc. Common Stock

NXT trades at $88.77, up 4.61% today, with strong analyst support (86% buy ratings) and a $144.67 consensus price target suggesting 63% upside. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results expected November 16. Revenue grew from $3.0B in 2025 to $3.6B in 2026, while maintaining robust profitability with 16.36% net margins and 27.22% ROE.

Positive outlook driven by $5.5B+ backlog and raised 2027 guidance, though rising platform investment costs and solar sector volatility present risks. Technical levels show support at $86 with resistance at $91, while valuation multiples (P/E 22.94, P/S 3.76) appear reasonable given growth trajectory.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $91.77, down 0.43% on the day, with a bullish technical signal supported by moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.07 exceeding expectations. Revenue growth remains steady at $8.23B for 2025, though net income margins have moderated from 13.84% in 2023 to 8.56% in 2025. The company maintains strong profitability with a 69.87% gross margin and recently announced a $0.24 quarterly dividend.

ZBH presents a mixed outlook with positive earnings momentum and analyst consensus price target of $103.11 offering 12% upside potential. However, rising debt levels and competitive pressures in medical technology pose risks. Institutional ownership trends show continued interest, with State Street increasing its position by 0.6% in Q3 2026. The stock's valuation at 22.35 P/E appears reasonable given the company's market leadership position.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NXT
100% Buy0% Sell
Avg holding period · 0 Days
ZBH

No sentiment data available yet.

Top news

Latest headlines on both assets

About Nextpower Inc. Common Stock

Nextpower Inc., formerly known as Nextracker, is a solar energy technology company that designs tracking systems, structural foundations, and electrical balance-of-system equipment for utility-scale solar power plants. The company also develops software for solar yield management and is expanding into utility-scale power conversion systems.

Read more on NXT →

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH →